RARA and squamous cell carcinoma: Previous reports indicated that RARαS77A, a phosphorylation-defective mutant of RARα, could mimic RARα hypo-phosphorylation and inhibit the proliferation of human squamous carcinoma, osteosarcoma, and AML cells [17–21].